Honeywell opens Munich Technical Centre

Published: 20-Jun-2011
Finance Analysis

Will provide German customers with support, training and centralised repair and maintenance services

Honeywell has opened a new Technical Centre in Munich, Germany to provide gas detection customers in the country with additional local services such as customer support, a training centre, and centralised repair and equipment maintenance services. The site will also house project engineering and r&d teams.

Ingo Löffler, Honeywell’s sales leader Semi/Hi-Tech EMEAI, said: ‘The new Technical Centre will enable us to deliver a more effective service, enhance our customer support and provide an easy to access training location for German and European customers. The Project Engineering and R&D teams on-site will also help us to develop tailor-made systems to specifically meet the needs of German customers.’

The 1,800m2 Technical Centre will include three fully equipped training suites, where customers can gain knowledge of a wide range of topics from the basics of gas detection to master classes on topics such as product certification.

See more

You may also like

Regulatory

Honeywell acquires life science-focused QMS provider

Read more
The acquisition further strengthens Honeywell's leadership in industrial automation, digital transformation solutions and enterprise performance management software

Trending Articles

  1. Sanofi completes acquisition of Blueprint Medicines Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation, adding to its portfolio a commercialised medicine and the expertise of a company specialising in systemic mastocytosis (SM) and other KIT-driven diseases
  2. Amphista Therapeutics reaches research milestone and triggers a milestone payment from Merck Collaboration focuses on the discovery of novel, non-CRBN/VHL, Targeted Glue degraders for oncology and immunology indications
  3. Strategic investment by Bain Capital, Kohlberg and Mubadala fuels PCI Pharma Services’ expansion This financial injection is expected to cement PCI’s position in the CDMO arena
  4. IMCD bolsters API portfolio with Trichem Healthcare acquisition This acquisition will bolster IMCD's portfolio of specialty pharmaceutical ingredients
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    FID: the gold standard in VOC emissions monitoring for more than 50 years Signal Group was one of the first companies in the world to develop VOC emissions analysers and, in the following article, the company’s Managing Director, James Clements, will explain why FID became the reference method ... and why it's lasted the test of time

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

You may also like

Regulatory

Honeywell acquires life science-focused QMS provider

The acquisition further strengthens Honeywell's leadership in industrial automation, digital transformation solutions and enterprise performance management software
Analysis

When is gas potentially fatal?

Following a move to new premises with custom-built service facilities, Ashtead Technology has extended its RAE/Honeywell servicing capabilities to help customers ensure the accuracy and reliability of their gas detection activities
Manufacturing

Honeywell launches double-certified reference materials for calibration of laboratory instruments

New generation of Hydranal accredited under ISO Guide 34 simplifies calibration of instruments for research laboratories
Research & Development

Lab Innovations adds major names to its show stopping exhibitor line-up

Lab Innovations 2016 welcomes back an array of leading industry suppliers from across the UK, spanning the entire laboratory spectrum
Ingredients

Honeywell completes purchase of Sigma-Aldrich's Research Chemicals Business

Adds Fluka, Hydranal and Chromasolv brands to portfolio
Manufacturing

AstraZeneca to invest $50 billion in US biopharma innovation and production

Company plans new Virginia manufacturing facility and R&D expansions to meet $80 billion revenue target by 2030
Finance

Sanofi completes acquisition of Blueprint Medicines

Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation, adding to its portfolio a commercialised medicine and the expertise of a company specialising in systemic mastocytosis (SM) and other KIT-driven diseases
Subscribe now